Pharma Investments, Ventures & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Certicom Corp.
Certicom Board Recommends Shareholders Reject Significantly Undervalued Hostile Bid from RIM
January 11th, 2009
Certicom Corp. (TSX-CIC.TO) ("Certicom" or "the Company") announced that its Board of Directors is advising its shareholders to reject the hostile offer of $1.50 per share from a wholly-owned subsidiary of Research in Motion Limited ("RIM"). After a thorough review involving both the Special Committee of independent directors and its financial and legal advisors, the Board found the RIM bid to be significantly undervalued, opportunistic and not in the best interests of Certicom shareholders. The Board's recommendation to shareholders not to tender to the RIM bid, and its reasons for the recommendation, are included in a Directors' Circular being sent...
Source: Pharma Investments, Ventures & Law Weekly (2009-01-11)
|
